Question 1

How can pharma companies use Scienza's real-world data for clinical trials?

Accepted Answer

Scienza Health provides access to 12.3M senior care patient records with 624K Alzheimer's and 420K Parkinson's patients for clinical trial recruitment, post-market surveillance, and drug utilization studies.

Question 2

What medication data is available for pharmaceutical research?

Accepted Answer

Our data lake contains 16.2B medication administration events with detailed dosing, timing, and outcome correlations across the senior care population.

Question 3

How does Scienza ensure data quality for pharma research?

Accepted Answer

All data is sourced from MDS 3.0 assessments with 920 clinical variables, validated through clinical workflows, and stored in HIPAA-compliant infrastructure on AWS.

Question 4

Can pharmaceutical companies access de-identified patient cohorts?

Accepted Answer

Yes, we provide de-identified cohorts segmented by diagnosis (Alzheimer's, Parkinson's, Heart Failure, Diabetes, COPD) with longitudinal outcome tracking.

Question 5

What post-market surveillance capabilities does Scienza offer?

Accepted Answer

Real-time monitoring of medication effects across 14,613 facilities with adverse event detection, drug interaction analysis, and outcome correlation.

Accelerate Drug Development with Real-World Evidence

Pre-Qualified Patient Populations
Ready for Clinical Trials

Pharmaceutical
Use Cases

Clinical Trial Recruitment

Post-Market Surveillance

Drug Utilization Patterns

Endpoint Monitoring

Current Applications in
Drug Development

Ready to Accelerate
Your Drug Development?

We value your privacy

Accelerate Drug Development with Real-World Evidence

Pre-Qualified Patient PopulationsReady for Clinical Trials

PharmaceuticalUse Cases